Results 191 to 200 of about 60,203 (254)

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2. [PDF]

Clin Cancer Res
Huffman BM, Diossy M, Yurgelun MB, Horick N, Li YY, Crowdis J, Nguyen H, Parmar K, Kochupurakkal BS, Vonk L, Lam H, Ramsey K, Andrews E, Loeb SC, Culnane L, Biller LH, Bullock AJ, Enzinger A, Giannakis M, Jackson NA, Ng K, Nowak JA, Patel AK, Perez KJ, Rattani A, Rubinson DA, Schlechter BL, Singh H, Cai M, Raghavan S, Clark JW, Peters ML, Weipert CM, Wolpin BM, D'Andrea AD, Shapiro GI, Aguirre AJ, Szallasi Z, Cleary JM.   +38 more
europepmc   +1 more source

Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriers. [PDF]

Fam Cancer
Laitman Y, Aharon K, Schloss T, Margolin L, Friedman E.   +4 more
europepmc   +1 more source

Investigating the contribution of rare non-coding variants in BRCA1, BRCA2 and PALB2 to hereditary breast cancer. [PDF]

NPJ Breast Cancer
Zhao Q, Li N, Marinovic E, McInerny S, Zethoven M, Devereux L, Canson DM, Spurdle AB, Scott RJ, James PA, Campbell IG.   +10 more
europepmc   +1 more source

Causative Role for a BRCA2 Germline Pathogenic Variant in External Auditory Canal Squamous Cell Carcinoma. [PDF]

Genes Chromosomes Cancer
Camacho-Valenzuela J, Pelletier D, Polak P, Fu L, Hamel N, Robles-Espinoza CD, Foulkes WD.   +6 more
europepmc   +1 more source

Double jeopardy: how <i>BRCA2</i>, <i>TP53</i>, and <i>DNMT3A</i> redefine the link between infertility and cancer risk. [PDF]

Front Cell Dev Biol
Huang Z, Abbas M, Hussain A, Long M, Muzammal M, Song K.   +5 more
europepmc   +1 more source

Case Report: Durable complete response to olaparib in a patient with BRCA2-driven metastatic gastric adenocarcinoma after failure of chemo-immunotherapy. [PDF]

Front Oncol
Karakaya G.
europepmc   +1 more source

Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy. [PDF]

Cancer Sci
Zennami K, Takimoto T, Nukaya T, Sumitomo M, Takeda M, Sugihara E, Saya H, Shiroki R.   +7 more
europepmc   +1 more source

Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer. [PDF]

Breast Cancer
Kano M, Taruno K, Inuzuka M, Makino R, Takeuchi M, Suzuki M, Kida K, Takei J, Nagayama A, Hayashida T, Haruyama Y, Ueno T, Watanabe C, Kojima Y, Sasai R, Endo M, Momozawa Y, Nakamura S.   +17 more
europepmc   +1 more source

Presence and prevalence of single nucleotide sequence polymorphisms in <i>TP53</i> and <i>BRCA2</i> genes as of cervical and ovarian cancers in women using hormonal contraceptives in Abuja, Nigeria. [PDF]

J Public Health Afr
Odebiyi OF, Kehinde A, Abdulsalami MS, Dibal DM.   +3 more
europepmc   +1 more source